2014 UK National Lipoprotein Apheresis Conference

Friday 7th March 2014, 09:00-1600

Venue: Hilton Manchester Airport Hotel, Manchester Airport, Outwood Lane, Manchester,

M90 4WP

CPD accreditation: 5 CPD applied for

University of Manchester The Centre for Endocrinology & Diabetes

0920-0930 Welcome: Dr Handrean Soran

Session 1

0930-1010 Underestimation of the importance of LDL-cholesterol lowering in cardiovascular disease prevention in current practice. Professor Paul Durrington, Professor of Medicine, University of Manchester, UK.

1010-1050 Lipoprotein (a) as a cardiovascular risk factor: review of evidence and therapeutic options. Dr Dermot Neely, Consultant in Clinical Biochemistry and Metabolic Medicine, Royal Victoria Infirmary, Newcastle, UK.

1050-1120 Coffee and networking

Session 2

1120-1200 HoFH; is it just double trouble? The role of the LDL-receptor in lipid metabolism and implications for therapeutic options. Dr Michael France, Consultant Chemical Pathologist, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.

1200-1240 Lipoprotein Apheresis: who and how should we treat? Dr Dev Datta, University Hospital Cardiff, Cardiff, UK.

1240-1350 Lunch

Session 3

1350-1430 Lomitapide as a therapeutic option for HoFH. Professor Claudia Stefanutti, Professor of Internal Medicine, Extracorporeal Therapeutic Techniques

Unit - Lipid Clinic and Atherosclerosis Prevention Centre, Department of Molecular Medicine ‘Sapienza’ University of Rome, Italy

1430-1500 Future therapeutic options for patients with HoFH. Dr Handrean Soran, Consultant Physician and Endocrinologist, Central Manchester University Hospital, UK.

1500-1530 Managing HoFH in children; challenges and options. Dr Andrew Morris, Consultant Paediatrician, Central Manchester University Hospitals NHS Foundation Trust.

1530-1550 Case discussions.

HoFH in children; pheresis as a therapeutic option. Mr Roy Connell, Apheresis specialist nurse, Nottingham University Hospital.

1600 Close

Sponsors: Aegerion, AMGEN, AstraZeneca, Link Medical, Sanofi.

Agenda

University of Manchester The Centre for Endocrinology & Diabetes

ATTENDANCE FORM

2014 UK National Lipoprotein Apheresis ConferenceFriday 7th March 2014, 09:30-1600

ManchesterCPD accreditation: 5 CPD applied for

YES, I am able to attend the meeting on Friday 7th March 2014

To reserve your place, please complete the form and return at your earliest convenience to Sister Ruth Eatough

Email: Ruth.Eatough@cmft.nhs.uk Fax: 0161 276 4684

CORRESPONDENCE DETAILSName: ……………………………………………………………………………………………………………………...

GP Surgery/Hospital: .…….………………………………………………………………………………………….Role/Position:…………………………………………………………………………………………………………… Address: ………………………………………………………………………………………………………………….. ………………………………………………………………………………………………………………………………..………………………………………………………………………………………………………………………………..Postcode: …………………………………………………………………………….......................................Contact Number: ……………………………………………………………………...................................

Email Address: …………………………………………………………………………………………………………

Please state any dietary requirements: …………………………………………………………………….

Signature: ………………………………………………………………………………………………………………..Date: …………………………………………………………………………………………………………………………

University of Manchester The Centre for Endocrinology & Diabetes